Mutation Impossible? How Multimodal Agents Are Rewriting Glioma Diagnostics
Report First, Diagnosis Second A medical report usually arrives after the diagnostic work is done. It explains, records, justifies, and sometimes politely hides how messy the evidence really was. This paper asks a more interesting question: what if the report itself becomes a predictive object? In Multimodal Oncology Agent for IDH1 Mutation Prediction in Low-Grade Glioma, Hafsa Akebli and colleagues build a Multimodal Oncology Agent, or MOA, for predicting IDH1 mutation status in low-grade glioma using TCGA-LGG data, whole-slide histology, structured clinical variables, genomic context, and external biomedical knowledge sources.1 The immediate headline is easy enough: the full multimodal setup reaches the best reported performance, with an F1-score of 0.912. ...